The role of nitric oxide (NO) in Mycobacterium bovis Bacillus Calmette Guérin (BCG) infection was investigated using nitric oxide synthase 2 (nos2)-deficient mice, because NO plays a pivotal ...

Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo. European Urology Focus, 2015; DOI: 10.1016/j.euf.2015.03.003 ...

A previous report of nosocomial infection due to Mycobacterium bovis bacille Calmette-Guerin (BCG) implicated contamination of chemotherapy solutions reconstituted under the same biosafety hood as BCG ...

Background. Using genotyping techniques that have differentiated Mycobacterium bovis from Mycobacterium tuberculosis since 2005, we review the epidemiology of human tuberculosis caused by M. bovis in ...

Universitat Autònoma de Barcelona. "Mycobacterium in olive oil for cancer treatment." ScienceDaily. ScienceDaily, 23 June 2016. <www.sciencedaily.com / releases / 2016 / 06 / 160623065240.htm>.

Researchers call for larger-scale assessments to measure the effectiveness of vaccination. A five-week consultation is open until 22 April to seek views from the public. A judge rules in favour of ...

Antitumor effect of cationic liposome incorporating keto-mycolic acid from Mycobacterium bovis bacillus Calmette-Guérin in mouse model. Authors: Takayuki Yoshino, Jun Miyazaki, Takahiro Kojima, Shuya ...

Besides, hunters in Michigan who submit deer heads that test positive for M. bovis might be at higher risk for infection, and targeted screening for tuberculosis could be performed,” the CDC warned.

Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely administered as a vaccine for tuberculosis. BCG is also used as a biotherapy for superficial bladder carcinoma.